Des Atouts Changement Date
AbbVie USD 147.68B 12.57B 2026-09
Abbott USD 108.25B 968M 2026-09
Amgen USD 96.05B 409M 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Baxter International USD 19.41B 377M 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Becton, Dickinson and Co. USD 50.79B 60M 2026-09
Biogen USD 32.05B 32.5M 2026-09
Boston Scientific USD 45.46B 245M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
CONMED USD 2.3B 4.16M 2026-09
Cooper Companies USD 12.67B 191.1M 2026-06
Dexcom USD 6.24B 216.5M 2026-09
Edwards Lifesciences USD 14.14B 277.3M 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Globus Medical USD 5.53B 39.93M 2026-09
Insulet USD 3.42B 250M 2026-09
Integra LifeSciences USD 3.51B 55.69M 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
J&J USD 197.42B 3.64B 2026-09
Medtronic USD 93.31B 278M 2026-06
Merck USD 132.77B 2.97B 2026-09
Merit Medical Systems USD 2.92B 61.29M 2026-09
Novartis USD 117.15B 4.88B 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.16B 5.29M 2026-09
Teva Pharmaceutical Industries USD 40.04B 185M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09
Zoetis USD 15.09B 11M 2026-09